☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Mylan Launches Hulio (adalimumab- biosimilar) in EU for Autoimmune Diseases
October 19, 2018
Mylan & Biocon Receive CHMP Recommendation to Ogivri (trastuzumab- biosimilar) for HER-2 Breast Cancer
October 19, 2018
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions